Symposium: New Evidence of Protection and Community Delivery of Intermittent Preventive Treatment of Malaria in Pregnancy
When: Friday 26 April 2024, 10:30-12:00 (CAT)
Where: Kigali Convention Centre, Room MH4
Organisers: London School of Hygiene & Tropical Medicine (LSHTM, UK), Kenya Medical Research Institute (KEMRI, Kenya) and Liverpool School of Tropical Medicine (LSTM, UK)
Over the past two decades, clinical trials have aimed to identify alternative drugs or strategies for the control of malaria in pregnancy among women with and without HIV infection. Meanwhile, coverage levels of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) have slowly increased.
This symposium aims to disseminate some of the most recent evidence from studies to enhance the uptake of IPTp-SP, studies that have looked at alternative regimens to replace SP for IPTp in areas of high SP-resistance in HIV-uninfected women, and studies that have investigated the addition of long-acting artemisinin-based combination therapy to daily co-trimoxazole in women living with HIV.
Agenda
Chairs:
- Matthew Chico, London School of Hygiene & Tropical Medicine (LSHTM, UK)
- Hellen Barsosio, Kenya Medical Research Institute (KEMRI, Kenya) and Liverpool School of Tropical Medicine (LSTM, UK)
Effect of community delivery of IPTp-SP on coverage in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique
Raquel González, Barcelona Institute for Global Health (ISGlobal, Spain)
Examining the potential non-malarial mechanisms underlying intermittent preventive treatment in pregnancy among HIV-uninfected women in East Africa: A systematic review and meta-analysis
Michelle Roh, University of California San Francisco (UCSF, United States)
Effects of metronidazole plus intermittent preventive treatment of malaria in pregnancy: a double-blinded randomised, partly placebo-controlled trial among women in Zambia without HIV (ASPIRE trial)
Mike Chaponda, Tropical Disease Research Centre (TDRC, Zambia)
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial (IMPROVE-2 trial)
Hellen Barsosio, KEMRI (Kenya)
Safety and efficacy of dihydroartemisinin-piperaquine for IPTp in HIV-infected pregnant women from Gabon and Mozambique (MAMAH trial)
Tacilta Nhampossa, Manhiça Health Research Center (CISM, Mozambique)